[Glucocorticoid-induced diabetes].
Ogawa
Yoshiji
Y
Third Department of Internal Medicine, Hirosaki University School of Medicine.
Tomotsune
Ken
K
Suda
Toshihiro
T
D000273:Adipose Tissue / Q000378:metabolism; D003920:Diabetes Mellitus / Q000139:chemically induced* / Q000188:drug therapy / Q000503:physiopathology; D005938:Glucocorticoids / Q000009:adverse effects*; D005943:Gluconeogenesis / Q000187:drug effects; D051275:Glucose Transporter Type 4; D006801:Humans; D007004:Hypoglycemic Agents / Q000627:therapeutic use; D007328:Insulin / Q000378:metabolism / Q000627:therapeutic use; D007333:Insulin Resistance; D008099:Liver / Q000378:metabolism; D009004:Monosaccharide Transport Proteins / Q000378:metabolism; D009124:Muscle Proteins / Q000378:metabolism; D009132:Muscles / Q000378:metabolism; D010179:Pancreas / Q000378:metabolism; D011972:Receptor, Insulin / Q000378:metabolism / Q000502:physiology; D015398:Signal Transduction / Q000187:drug effects
D005938:Glucocorticoids; D051275:Glucose Transporter Type 4; D007004:Hypoglycemic Agents; D007328:Insulin; D009004:Monosaccharide Transport Proteins; D009124:Muscle Proteins; C495692:SLC2A4 protein, human; D011972:Receptor, Insulin